March 14, 2025

Ron Finklestien

Join MRVI Investors in Leading a Securities Fraud Lawsuit Against Maravai LifeSciences Holdings, Inc. with the Schall Law Firm


Maravai LifeSciences Faces Class Action Over Alleged Securities Violations

LOS ANGELES, March 14, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, is reminding investors about a class action lawsuit against Maravai LifeSciences Holdings, Inc. (“Maravai” or “the Company”) MRVI for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 established by the U.S. Securities and Exchange Commission.

(PRNewsfoto/The Schall Law Firm)

Investors who bought the Company’s securities between August 7, 2024 and February 24, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before May 5, 2025.

Shareholders who experienced losses are invited to participate in the lawsuit. You may reach out to Brian Schall of the Schall Law Firm at 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335 to discuss your rights at no cost. Additional information is available on the firm’s website at www.schallfirm.com, or via email at [email protected].

The class in this case has not yet been certified. Without certification, potential participants are not currently represented by an attorney. If you choose to not participate, you will remain an absent class member.

According to the Complaint, the Company issued false and misleading statements affecting the market. Maravai allegedly failed to maintain adequate internal controls over financial reporting and improperly recognized revenue from certain transactions in fiscal 2024. The Company also overstated its goodwill. These factors rendered the Company’s public statements false and materially misleading throughout the Class Period. When the market became aware of these realities, investors faced financial setbacks.

Investors are encouraged to join the case to seek recovery for their losses.

The Schall Law Firm represents investors globally and focuses on securities class action lawsuits and shareholder rights litigation.

Please note that this press release may be considered Attorney Advertising in some jurisdictions under applicable law and ethics rules.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.
www.schallfirm.com
Office: 310-301-3335
[email protected]

Cision
View original content to download multimedia: here

SOURCE The Schall Law Firm


Subscribe to Pivot and Flow Daily